A young woman is reviews stocks on her computers at night. The best dividend stocks of June 2026 were screened by analyzing dividend safety, total return context and current macro fit.
Getty
The current interest rate picture is murkier than most investors would like. The Federal Reserve held its benchmark rate steady at 3.5%–3.75% for a third consecutive meeting in late April. In a notable sign of internal fracture, the vote split 8 to 4, the most divided FOMC in over three decades. With inflation keeping the Fed sidelined and energy prices elevated due to Middle East tensions, income investors can’t count on rate cuts doing the heavy lifting for them this summer.
The dividend growth story, however, doesn’t need a rate cut to work — it needs earnings durability, pricing power and balance sheets that don’t rely on cheap refinancing to sustain the payout. This month’s best dividend stock picks reflect that reality, and could be worth considering if you’re adding to an existing income portfolio or building one as a beginner heading into the second half of 2026.
5 Top Dividend Stocks To Buy Now For June 2026
I screened for names with documented dividend safety, above-market or growing yields and the kind of business model resilience that holds up when the macro backdrop gets complicated. Each one sits on Dividend.com’s top stocks model portfolio list and carries a Dividend Safety rating between 3.7 and 4.5 (scale out of 5).
Selecting this month’s list came down to three filters applied in sequence.
- Dividend safety: We only considered names with a Dividend Safety score of 3.7 or higher on Dividend.com’s proprietary scale, which evaluates payout sustainability across cash flow coverage, balance sheet health, and earnings stability.
- Total return context: A stock sitting well below its price recommendation tells a different story than one trading at a premium to it, and that spread informs our conviction level.
- Current macro fit: In an environment where rates are on hold and credit stress is rising, businesses with inelastic demand, regulated revenue streams or exceptional execution quality get preference.
The five stocks that cleared all three filters span four sectors and a wide range of market caps, from American States Water’s $3 billion to AbbVie’s $358 billion. What they share is a credible case for dividend continuity, a yield that beats the S&P 500’s average, and a business that doesn’t depend on things going right in Washington or overseas for the income check to arrive.
1. American States Water Co. (AWR)
AWR Business Overview
- Sector / Industry: Utilities / Water Utility
- Market Cap: $3.01 billion
- Forward Dividend / Yield: $2.02 / 2.61%
- YTD Total Return: +6.74%
- EPS (Q1 2026): $0.76 diluted; Full-Year Consensus: ~$3.74
American States Water has been increasing its dividend for over 70 consecutive years, a streak that puts it among the most durable income instruments in the entire U.S. equity market. The company operates regulated water and electric utilities in California through Golden State Water Company and Bear Valley Electric Service, and runs water and wastewater systems on U.S. military bases through its contracted services segment.
In Q1 2026, AWR reported diluted EPS of $0.76, up 8.6% year-over-year, driven by new CPUC-approved rate increases, stronger electric revenues and higher construction activity in its military services business. Full-year consensus sits around $3.74 per share.
Why AWR Stock Is A Top Choice
AWR earns its place on this list primarily because of what it isn’t. It isn’t dependent on discretionary consumer spending, it isn’t exposed to floating-rate refinancing risk and it isn’t in a business that faces competitive disruption. Water is water.
The California Public Utilities Commission rate structure provides a regulated return on equity that gives management reasonable earnings visibility regardless of what happens with tariffs or energy prices. At $77.20, AWR is trading above its $71.73 price recommendation, which reflects the flight-to-quality premium this kind of business commands when the macro outlook is unsettled.
2. Procter & Gamble Co. (PG)
PG Business Overview
- Sector / Industry: Consumer Staples / Household Products
- Market Cap: $340.12 billion
- Forward Dividend / Yield: $4.35 / 2.97%
- YTD Total Return: +3.39%
- EPS (Q3 FY26 Diluted): $1.63; Core EPS: $1.59; FY26 Guidance: $6.83–$7.09
Procter & Gamble has a 69-year streak of consecutive dividend increases. It has survived oil shocks, financial crises, a pandemic and the most aggressive rate-hiking cycle in 40 years while raising its dividend every single year.
P&G’s Q3 FY2026 results delivered diluted EPS of $1.63, up 6% year over year, with core EPS of $1.59 up 3%. The company reaffirmed its FY2026 guidance of $6.83 to $7.09 in core EPS — a range that prices in a $400 million after-tax tariff headwind and still projects modest growth. Organic sales grew 3% in the quarter, driven by volume across its ten product categories.
Why PG Stock Is A Top Choice
P&G is the textbook definition of a stock you own when uncertainty spikes. Its portfolio of household brands — Tide, Pampers, Gillette, Dawn — commands enough shelf-space dominance and brand loyalty that consumers absorb price increases rather than trade away. That pricing power is what makes the 2.97% forward yield sustainable and growing: the company isn’t paying its dividend out of accounting tricks, it’s paying it out of the relentless cash generation of brands people buy every week regardless of the economic cycle. At $146.42, PG is slightly above its $144.27 recommendation price, but the proximity is close enough that dollar-cost averaging here makes sense for long-term income investors.
3. Popular, Inc. (BPOP)
BPOP Business Overview
- Sector / Industry: Financials / Banking
- Market Cap: $9.67 billion
- Forward Dividend / Yield: $3.00 / 2.01%
- YTD Total Return: +20.22%
- EPS (Q1 2026): $3.78 diluted — 48% above year-ago level, 13.3% beat vs. consensus
Popular, Inc. is Puerto Rico’s dominant financial institution and the parent of Banco Popular, the island’s largest bank, as well as Popular Bank on the mainland U.S. The company reported EPS of $3.78 during Q1 2026, up 48% year-over-year, beating consensus by over 13%, with net income of $245.7 million driven by net interest income of $670.2 million, expanding margins, and disciplined expense control. Return on tangible common equity improved to 15.5%.
Why BPOP Stock Is A Top Choice
BPOP’s 20.22% YTD return leads this list by a wide margin, and more importantly, it was driven by actual earnings power rather than multiple expansion. Popular’s net interest margin held above 3.7% in Q1 even as mainland banks face NIM compression. BPOP offers a combination of dividend growth, earnings momentum, and valuation that is genuinely hard to replicate elsewhere.
4. Mondelēz International, Inc. (MDLZ)
MDLZ Business Overview
- Sector / Industry: Consumer Staples / Packaged Food
- Market Cap: $78.59 billion
- Forward Dividend / Yield: $2.00 / 3.25%
- YTD Total Return: +15.95%
- EPS (Q1 2026): $0.44 GAAP diluted; $0.67 adjusted — beat consensus of $0.61
Mondelēz International is the global snacking giant behind Oreo, Cadbury, Toblerone and Ritz, generating revenues across more than 150 countries.
The company reported Q1 2026 results with revenue up 8.2% year over year to $10.08 billion and adjusted EPS of $0.67, beating the consensus estimate of $0.61. Net organic revenues grew 3% despite elevated cocoa costs, a headwind that has pressured margins but not derailed the underlying business. Management reaffirmed its 2026 organic revenue growth outlook, signaling confidence in the demand environment for its snacking portfolio. MDLZ carries the lowest Dividend Safety score on this list at 3.7, primarily reflecting the commodity input exposure.
Why MDLZ Stock Is A Top Choice
The reason MDLZ makes the June 2026 list is simple: at $61.55, it is trading at a meaningful discount to its $74.41 price recommendation on dividend.com — a gap of nearly 17%. That spread reflects the market’s near-term worry about cocoa costs and consumer confidence in key European markets. But Mondelēz’s snacking brands are among the stickiest in the consumer staples universe — the company has successfully passed through price increases in previous commodity shock cycles and maintained volume share. The 3.25% forward yield is the third-highest on this list, and with the stock sitting well below the price target, income investors are getting both an above-average yield and a meaningful potential total return as the commodity headwind eventually normalizes.
5. AbbVie Inc. (ABBV)
ABBV Business Overview
- Sector / Industry: Health Care / Large Pharma
- Market Cap: $358.43 billion
- Forward Dividend / Yield: $6.92 / 3.43%
- YTD Total Return: -9.82%
- EPS (Q1 2026): $2.65 adjusted diluted; FY26 Guidance: $13.96–$14.16 adjusted
AbbVie’s -9.82% YTD return makes it the sole underperformer on this list, and that’s exactly why it’s here. The selloff is primarily a sentiment story tied to Humira biosimilar competition and near-term acquired IPR&D charges, not a structural break in the dividend engine.
Its Q1 2026 adjusted EPS came in at $2.65, broadly in line with the $2.66 consensus, with full-year adjusted guidance of $13.96 to $14.16 per share. The $6.92 forward annual dividend is the highest dollar payout on this list, and at $201.55, the stock trades at a modest premium to its $189.65 price recommendation, though the YTD dip has compressed that premium considerably from where it was earlier in the year.
Why ABBV Stock Is A Top Choice
AbbVie’s pipeline has materially de-risked the Humira cliff concern that dominated the narrative for most of 2024 and 2025. Skyrizi and Rinvoq are both growing at double-digit rates and have become multi-billion-dollar franchises in their own right, with label expansions underway in Crohn’s disease and atopic dermatitis. The 3.43% forward yield is the highest on this list, and with a Dividend Safety score of 4.1, the payout is not in question despite the headline EPS volatility from acquired IPR&D charges — a standard pharmaceutical accounting item, not an operational problem. Investors who bought AbbVie at the beginning of a prior down cycle and held have been well rewarded.
With the Fed on hold, credit spreads widening, and geopolitical uncertainty elevating energy costs, quality and durability are what the income investor’s portfolio needs above all else. BPOP stands out for raw momentum; MDLZ for its discount-to-recommendation value opportunity; ABBV for its yield and pipeline recovery story; and AWR and PG for the kind of all-weather durability that anchors any income portfolio worth building.